BTIG Research Trims Zimmer Biomet (NYSE:ZBH) Target Price to $126.00
Zimmer Biomet (NYSE:ZBH – Free Report) had its price objective decreased by BTIG Research from $134.00 to $126.00 in a research report sent to investors on Thursday morning, Benzinga reports. BTIG Research currently has a buy rating on the medical equipment provider’s stock. ZBH has been the topic of a number of other research reports. […]
6 Oct 07:16 · The Markets Daily